174 related articles for article (PubMed ID: 20394697)
1. Factors associated with cervical cancer screening in Puerto Rico.
Ortiz AP; Hebl S; Serrano R; Fernandez ME; Suárez E; Tortolero-Luna G
Prev Chronic Dis; 2010 May; 7(3):A58. PubMed ID: 20394697
[TBL] [Abstract][Full Text] [Related]
2. Cervical Cancer Screening and Sexual Risky Behaviors among a Population of Hispanic Origin.
González D; Suárez EL; Ortiz AP
Womens Health Issues; 2015; 25(3):254-61. PubMed ID: 25840931
[TBL] [Abstract][Full Text] [Related]
3. Breast and cervical cancer screening practices among Hispanic women in the United States and Puerto Rico, 1998-1999.
Coughlin SS; Uhler RJ
Prev Med; 2002 Feb; 34(2):242-51. PubMed ID: 11817921
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
5. Do age-based discontinuation recommendations influence cervical cancer screening rates? Evidence from the United States' Behavioral Risk Factor Surveillance System, 2016 and 2018.
Estenson L; Kim N; Jacobson M
Prev Med; 2023 Jul; 172():107543. PubMed ID: 37182584
[TBL] [Abstract][Full Text] [Related]
6. Breast, cervical, and colorectal cancer screening test use in the US territories of Guam, Puerto Rico, and the US Virgin Islands.
Gopalani SV; Soman A; Shapiro JA; Miller JW; Ortiz-Ortiz KJ; Castañeda-Avila MA; Buenconsejo-Lum LE; Fredericks LE; Tortolero-Luna G; Saraiya M
Cancer Epidemiol; 2023 Jun; 84():102371. PubMed ID: 37105018
[TBL] [Abstract][Full Text] [Related]
7. State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.
Ahluwalia IB; Mack KA; Murphy W; Mokdad AH; Bales VS
MMWR Surveill Summ; 2003 Aug; 52(8):1-80. PubMed ID: 14532868
[TBL] [Abstract][Full Text] [Related]
8. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
Tiruneh FN; Chuang KY; Ntenda PAM; Chuang YC
BMC Womens Health; 2017 Nov; 17(1):109. PubMed ID: 29141612
[TBL] [Abstract][Full Text] [Related]
9. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
Al Rifai R; Nakamura K
Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
[TBL] [Abstract][Full Text] [Related]
10. Determinants of Potentially Unnecessary Cervical Cancer Screenings in American Women.
Seo M; Langabeer II JR
J Prev Med Public Health; 2018 Jul; 51(4):181-187. PubMed ID: 30071705
[TBL] [Abstract][Full Text] [Related]
11. Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk?
Coughlin SS; Uhler RJ; Hall HI; Briss PA
Prev Chronic Dis; 2004 Jan; 1(1):A04. PubMed ID: 15634366
[TBL] [Abstract][Full Text] [Related]
12. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening in the US-Mexico border region: a binational analysis.
Herrera DG; Schiefelbein EL; Smith R; Rojas R; Mirchandani GG; McDonald JA
Matern Child Health J; 2012 Dec; 16 Suppl 2(0 2):298-306. PubMed ID: 22965734
[TBL] [Abstract][Full Text] [Related]
14. Papanicolaou testing among women in the southern United States.
Peterson NB; Murff HJ; Cui Y; Hargreaves M; Fowke JH
J Womens Health (Larchmt); 2008; 17(6):939-46. PubMed ID: 18582173
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
Sumarmi S; Hsu YY; Cheng YM; Lee SH
Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening in the United States, 1993-2010: characteristics of women who are never screened.
Chen HY; Kessler CL; Mori N; Chauhan SP
J Womens Health (Larchmt); 2012 Nov; 21(11):1132-8. PubMed ID: 22873781
[TBL] [Abstract][Full Text] [Related]
17. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Pap smear screening results between Akha hill tribe and urban women in Chiang Rai province, Thailand.
Kritpetcharat O; Wutichouy W; Sirijaichingkul S; Kritpetcharat P
Asian Pac J Cancer Prev; 2012; 13(11):5501-4. PubMed ID: 23317207
[TBL] [Abstract][Full Text] [Related]
19. Breast and cervical cancer screening among women in metropolitan areas of the United States by county-level commuting time to work and use of public transportation, 2004 and 2006.
Coughlin SS; King J
BMC Public Health; 2010 Mar; 10():146. PubMed ID: 20302614
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study.
Schumacher MC; Slattery ML; Lanier AP; Ma KN; Edwards S; Ferucci ED; Tom-Orme L
Cancer Causes Control; 2008 Sep; 19(7):725-37. PubMed ID: 18307048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
